Illinois HB2874 amends the Controlled Substances Act to exempt certain ephedrine products from over-the-counter sale restrictions.
Illinois HB2874 amends the Illinois Controlled Substances Act to exempt certain ephedrine products from over-the-counter sale restrictions. Specifically, it exempts products that are lawfully sold over-the-counter under federal law, labeled and marketed in compliance with federal regulations, and manufactured for legitimate medicinal use. The bill also exempts products containing naturally occurring ephedrine or its derivatives, provided they are in a matrix of organic material and do not exceed 15% of the total weight.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.